| Frequency | Percent |
Number of patients | 62 | 100% |
Age (year) ≤60 >60 | 43 - 75 (mean 61) 36 26 |
58.1% 41.9% |
Gender Male Female |
56 6 |
90.3% 9.7% |
Performance 0 1 2 |
5 39 18 |
9.7% 80.6% 9.7% |
Child-Pugh Classification A B |
51 11 |
82.3% 17.7% |
T. bilirubin (mg/dl) <2 2 - 3 >3 |
53 5 4 |
85.5% 8% 6.5% |
Albumin (gm/dl) >3.5 2.8 - 3.5 <2.8 |
41 19 2 |
66.1% 30.6% 3.3% |
INR <1.7 1.7 - 2.3 >2.3 |
60 2 0 |
96.7% 3.3% 0% |
HCV +ve −ve |
43 19 |
69.4% 30.6% |
HBV +ve −ve |
5 57 |
8.1% 91.9% |
AFP (ng/ml) <400 ≥400 |
9 53 |
14.5% 85.5% |
Tumor location Hemiliver Bilobar (Both hemilivers) |
16 46 |
25.8% 74.2% |
Tumor type Unifocal Multiple/Diffuse |
10 52 |
16.1% 83.9% |
Tumor maximum diameter (cm) ≤6 >6 |
18 44 |
29% 71% |
Thrombus maximum diameter (cm) ≤3 >3 |
15 47 |
24.2% 75.8% |
Thrombus site PV main trunk PV branch PV trunk + branch(es) |
15 5 42 |
24.2% 8.1% 67.7% |
HCV = Hepatitis-C virus, HBV = Hepatitis B virus, AFP = alpha-fetoprotein |